The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage
Egido, J.; Gómez-Chiarri, M.; Lerma, J.L.; González, E.; Maestre, C.; Ortiz, A.; Hernando, L.
Revista Clinica Espanola 187(3): 137-143
1990
ISSN/ISBN: 0014-2565 PMID: 2284487 Document Number: 365207
Document emailed within 1 workday
Related Documents
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Inui, K. 1993: Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass Nihon Kyobu Geka Gakkai 41(2): 238-246
Perico, N.; Delaini, F.; Tagliaferri, M.; Abbate, M.; Cucchi, M.; Bertani, T.; Remuzzi, G. 1988: Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney Laboratory Investigation; a Journal of Technical Methods and Pathology 58(2): 163-171
Stahl, G.L.; Terashita, Z.; Lefer, A.M. 1988: Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia Journal of Pharmacology and Experimental Therapeutics 244(3): 898-904
Konturek, S.J.; Brzozowski, T. 1991: Role of leukotrienes and platelet activating factor in gastric mucosal damage and repair Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 42(2): 107-133
Coker, A.; Coker, I.; Huseyinov, A.; Sokmen, S.; Karademir, S. 2001: Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? Hepato-Gastroenterology 48(40): 1134-1137
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Farr, R.S.; Wardlow, M.L.; Cox, C.P.; Meng, K.E.; Greene, D.E. 1983: Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Federation Proceedings 42(14): 3120-3122
Gereliuk, I.P.; Stukal, I.V. 1991: Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia Kardiologiia 31(1): 82-83
Valone, F.H.; Epstein, L.B. 1988: Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1-beta, tumor necrosis factor, or IFN-gamma Journal of Immunology 141(11): 3945-3950
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Page, C.P. 1986: Platelet activating factor, ketotifen and asthma New Zealand Medical Journal 99(812): 818
McManus, L.M.; Deavers, S.I. 1989: Platelet activating factor in pulmonary pathobiology Clinics in Chest Medicine 10(1): 107-118
Foa, R.; Bussolino, F.; Ferrando, M.L.; Guarini, A.; Tetta, C.; Mazzone, R.; Gugliotta, L.; Camussi, G. 1985: Release of platelet-activating factor in human leukemia Cancer Research 45(9): 4483-4485
Fraj Lázaro, J.; Hinojosa Macías, M.; Puyana Ruiz, J. 1991: Platelet activating factor in the physiopathology of bronchial asthma Medicina Clinica 96(1): 30-34